Back to Studies Nutritional Intervention to Prevent (NIP) Diabetes

Diabetes Prevention Trial
Nutritional Intervention to Prevent (NIP) Diabetes

Families are Needed Who Have an Infant Under age 5 Months or a Mother in the Last Trimester of Pregnancy and a Family Member with Type 1 Diabetes

Families fitting the above criteria are asked to consider enrolling in a federally (NIH) sponsored pilot trial which could eventually be important in reversing the increasing incidence of type 1 diabetes. In the trial, both treatment and control infant formulas provide a source of omega 3 fatty acids (two different dosages) which do not come from fish (so do not have to worry about mercury, pesticides or other contaminants). Mothers can start in the last trimester of pregnancy or infants must start before age 5 months.

The current data is that 90% of infants developing diabetes by age 13 years have the initial damage (islet-cell antibodies) by age 3 years. It is thus important to start with prevention at an early age. Epidemiologic data recently published in the Journal of the American Medical Association (vol 298, page 1420, 2007) supports the importance of this study.

There are 9 sites conducting the study. Please contact Sara Adams (301) 231-6867 or for more information.

January 14, 2008

For More Information

[ Back to Studies Page ]

  Back to Studies Return to the Top of This Page

Last Updated: Monday January 14, 2008 18:09:54
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.